Bush Investment Group LLC acquired a new position in shares of BlackRock U.S. Equity Factor Rotation ETF (NYSEARCA:DYNF – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 27,419 shares of the company’s stock, valued at approximately $1,140,000. BlackRock U.S. Equity […]
Thomasville Bancshares, Inc. (OTCMKTS:THVB – Get Free Report) was the target of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 400 shares, an increase of 300.0% from the April 30th total of 100 shares. Based on an average daily trading volume, of 1,000 […]
Thomasville Bancshares, Inc. (OTCMKTS:THVB – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 400 shares, a growth of 300.0% from the April 30th total of 100 shares. Based on an average trading volume of 1,000 shares, the days-to-cover ratio […]
Principal Securities Inc. bought a new position in Vanguard Russell 1000 Growth ETF (NASDAQ:VONG – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 569 shares of the company’s stock, valued at approximately $44,000. Several other hedge funds also recently modified […]
Jefferies Financial Group downgraded shares of Danimer Scientific (NYSE:DNMR – Free Report) from a buy rating to a hold rating in a research report released on Wednesday morning, MarketBeat Ratings reports. Jefferies Financial Group currently has $0.80 price objective on the stock, down from their previous price objective of $1.30. Other equities research analysts have […]
Jefferies Financial Group downgraded shares of Danimer Scientific (NYSE:DNMR – Free Report) from a buy rating to a hold rating in a research note released on Wednesday, Marketbeat.com reports. They currently have $0.80 price target on the stock, down from their previous price target of $1.30. Several other research analysts have also recently weighed in […]
scPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) – Analysts at Leerink Partnrs lifted their FY2026 EPS estimates for scPharmaceuticals in a research report issued on Tuesday, May 14th. Leerink Partnrs analyst R. Ruiz now anticipates that the company will post earnings of $0.80 per share for the year, up from their prior estimate of $0.75. The […]
scPharmaceuticals' (SCPH) "Buy" Rating Reaffirmed at HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.